Michael is a neuropsychologist and methodologist who provides critical decision support to clients commercializing new therapies and healthcare solutions. He provides intellectual leadership on a diverse set of topics ranging from launch strategy and life cycle management to health economics and regulatory compliance. Michael earned a PhD from Cambridge University.
In addition to using essential cookies that are necessary to provide you with a smooth navigation experience on the website, we use other cookies to improve your user experience. To respect your privacy, you can adjust the selected cookies. However, this might affect your interaction with our website. Learn more about the cookies we use.
